Gate for Bacterial Toxins Found
Researchers discover a molecule that smuggles toxins from intestinal pathogens into human cells
Panagiotis Papatheodorou
Clostridia cause intestinal and wound diseases in humans and animals that are often fatal. “At the moment, infections with the bacterium Clostridium difficile are particularly problematic in hospitals. The diseases tend to appear following treatment with antibiotics and often lead to diarrhea, but also to fatal inflammations of the bowels,” explains Aktories. The toxins force their way into host cells and deactivate signaling molecules by attaching a sugar molecule to these cellular switches. Once this signaling pathway has been switched off, the cell dies – infested tissue dies off.
In order to find the receptor, the researchers applied a genetic selection procedure, a so-called screening, in which individual genes in cells from human cancer cell lines are turned off at random. This procedure led to the discovery that cells are immune to the TpeL toxin when the gene for the protein LRP1 is switched off on the cell surface. LRP1, which stands for low density lipoprotein receptor-related protein 1, usually takes in proteins that serve as a means of transport for lipids in the blood. The researchers demonstrate that LRP1 is the long sought-after key molecule: It also regulates the intake of the toxin TpeL.
His team also proposes a new model, explains Aktories: “Our findings indicate that two receptors are involved in the effect of the other sugar-carrying clostridial toxins.” Researchers can use the findings to develop new agents against clostridia. “Our discovery will also provide new impetus for researchers to identify further toxin receptors,” Aktories hopes.
Original publication
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.